YOLFTbeta
SC

SCS Stem Cells Spin

SCS · WAR · Healthcare / Biotechnology

0.51PLN+0.02 (+4.08%)

Price History

Full chart

Market Stats

Previous Close0.49
Open0.49
Day Range0.47 – 0.51
52-Week Range0.28 – 0.54
Volume3.22K
Market Cap45.47M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.0067
Dividend Yield0.00%
50-Day Avg0.00
200-Day Avg0.00

About

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and usage of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name. The company was founded in 2009 and is based in Wroclaw, Poland. Stem Cells Spin S.A. operates as a subsidiary of Medcervin Sp. Z O.O.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOAdam Symber
  • Employees0
  • HeadquartersBETA Building, Wroclaw, Poland, 54-413, Poland
  • Websitehttps://stemcellsspin.com.pl

Leadership

  • Adam SymberPresident of Management Board

Financials

Income Statement

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue712.49K1.88M435.56K524.35K582.15K268.32K525.92K247.80K419.32K54.28K65.74K
Growth (%)-+164.23%-76.86%+20.39%+11.02%-53.91%+96.00%-52.88%+69.22%-87.06%+21.11%
Cost of Revenue-219.40K29.34K-236.35K63.90K89.44K6.97K23.74K19.94K44.62K7.51K4.85K
Gross Profit931.89K1.85M671.91K460.45K492.71K261.35K502.18K227.86K374.71K46.77K60.89K
Gross Margin130.79%98.44%154.26%87.81%84.64%97.40%95.49%91.95%89.36%86.17%92.63%
Operating Expense807.18K1.04M629.35K925.37K1.19M219.64K578.99K436.83K525.14K563.25K580.27K
Operating Income124.71K809.20K42.56K-464.92K-700.52K41.71K-76.81K-208.97K-150.43K-516.48K-519.38K
Operating Margin17.50%42.98%9.77%-88.67%-120.33%15.54%-14.60%-84.33%-35.88%-951.51%-790.10%
EBITDA-------981.72K932.15K981.37K1.01M
EBITDA Margin-------396.17%222.30%1807.98%1532.73%
Net Income123.98K746.40K32.25K-521.74K-723.15K6.41K-127.41K26.61K-154.35K-520.27K-525.63K
Net Income Margin17.40%39.65%7.40%-99.50%-124.22%2.39%-24.23%10.74%-36.81%-958.49%-799.60%
Interest Expense0000035.31K42.90K735.931.21K3.79K5.69K
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%13.16%8.16%0.30%0.29%6.98%8.65%

Balance Sheet

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets21.07M21.16M21.25M19.16M17.23M14.86M17.08M14.80M13.61M11.02M9.57M
Total Liabilities16.02M16.24M16.18M8.95M7.75M7.18M9.53M7.22M6.18M4.12M3.19M
Total Equity5.04M4.92M5.07M10.21M9.48M7.68M7.55M7.58M7.43M6.91M6.38M
Cash---650650650594.10K61.87K6.25K2.67K77.15K
Total Debt6.33M5.29M6.72M1.31M1.14M593.28K-----
Net Debt----1.13M974.39K-288.58K-69.63K84.94K

Cash Flow

Currency: PLN2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow820.46K-870.18K-323.21K10.31M126.98K187.60K658.77K-598.42K341.20K3.33M-85.92K
Investing Cash Flow-9.97M-626.69K--10.42M-------
Financing Cash Flow7.67M1.05M249.48K175.26K-182.22K-170.00K-----
Capital Expenditure6.23M22.14K010.42M0000247.46K3.29M0
Free Cash Flow-----187.60K658.77K-598.42K93.74K43.42K-85.92K
FCF to OCF-----100.00%100.00%100.00%27.47%1.30%100.00%

Key Statistics & Ratios

Market Cap45.47M
Enterprise Value0
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.00
Price / Book0.00
EPS-0.0067
Revenue (TTM)0
Gross Profit (TTM)0
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-288.74%
Return on Assets0.00%
Shares Outstanding0
Shares Float0
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%